NCT00032734View on ClinicalTrials.gov

Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

July 31, 2003

Conditions
Syndrome of Inappropriate ADH (SIADH) SecretionHyponatremia
Interventions
DRUG

satavaptan (SR121463B)

Trial Locations (4)

Unknown

Sanofi-aventis Administrative Office, Diegem

Sanofi-aventis Administrative Office, Paris

Sanofi-aventis Administrative Office, Berlin

Sanofi-aventis Administrative Office, Budapest

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY